Biomarker concepts for early cancer detection – Kim Pettersson

The primary focus of our group is to design new concepts for early cancer detection and precision management with novel biomarkers and test technologies.

Our research combines biomarker discovery, antibody and assay development and clinical validation addressing a broad range of cancers. The research group is a blend of experienced researchers, early stage researchers and technicians led by professor Kim Pettersson and docent Janne Leivo.

Read more: